PRA Health Sciences, Inc.(PRAH): For the most recent quarter end, PRA Health Sciences, Inc. reported Annual Earnings of $0.62. Based on the filings, last years Annual Earnings was, $1.94. For the most recent quarter end, PRAH reported a surprise Earnings per Share of 0% . The consensus estimate for current quarter is $0.64 and for the current fiscal year, the estimate is $2.39. For the Next fiscal year, the estimate is $2.96 based on the consensus.
PRA Health Sciences, Inc. has received $0.64 as the consensus Earnings Estimate for the Quarter ending on Dec 2016 ,According to the estimate provided by 6 Financial Advisor in the Stock Trading Firms. Among 6 Analysts, Bottom line EPS Estimate for the current quarter is $0.63 while the top line estimate is $0.64 , a key information to consider for Day Trading and investing in stocks. The EPS growth rate is projected at 11.4%.
PRA Health Sciences, Inc. has a Price to Earnings ratio of 26.05 for the trailing twelve month period. The price to book ratio of the company for the most recent quarter is 5.01. For the Most Recent Fiscal Year, PRA Health Sciences, Inc. has a price to cash ratio of 17.62. For the Trailing twelve month period, company showed a Net Profit Margin of 4.86% and Return on Equity of the stock is 21.25%.
PRA Health Sciences Inc Last issued its quarterly earnings results on Feb 22, 2017. The company reported $0.71 EPS for the quarter, beating the analyst consensus estimate by $ 0.07. Analyst had a consensus of $0.64. The company had revenue of $413.61 million for the quarter, compared to analysts expectations of $405.04 million. The companys revenue was up 14.2% compared to the same quarter last year. During the same quarter in the previous year, the company posted $0.59 EPS.
Company has reported several Insider transactions to the SEC, on Aug 22, 2016, Colin Shannon (President & CEO) sold 113,133 shares at 51.58 per share price.On Aug 17, 2016, Linda Baddour (Executive VP & CFO) sold 69,380 shares at 52.00 per share price.On Aug 15, 2016, David W Dockhorn (Executive VP & CCO) sold 107,257 shares at 49.00 per share price.
PRA Health Sciences, Inc. (NASDAQ:PRAH) witnessed a decline in the market cap on Wednesday as its shares dropped 1.17% or 0.71 points. After the session commenced at $60.49, the stock reached the higher end at $60.77 while it hit a low of $59.52. With the volume soaring to 623,831 shares, the last trade was called at $59.98. The company has a 52-week high of $61.5. The company has a market cap of $3,683 million and there are 61,408,892 shares in outstanding. The 52-week low of the share price is $39.25.
PRA Health Sciences, Inc. operates as a global contract research organizations providing outsourced clinical development services to the biotechnology and pharmaceutical industries. It offers therapeutic services in the areas of cardio-metabolic, biosimilars, infectious diseases, immunology, neurology and psychiatry, oncology and hematology, rare diseases, and respiratory needs. The Company engages in bioanalytical laboratory, clinical pharmacology, clinical development, strategic solutions, post marketing research, clinical informatics, clinical diagnostics, and safety and risk management activities. PRA Health Sciences, Inc. is based in Raleigh, North Carolina.